| Structure, function and polymorphism of human cytosolic sulfotransferases Y Li, J Lindsay, LL Wang, SF Zhou Current drug metabolism 9 (2), 99-105, 2008 | 196 | 2008 |
| The development and evaluation of an oncological palliative care deprescribing guideline: the ‘OncPal deprescribing guideline’ J Lindsay, M Dooley, J Martin, M Fay, A Kearney, M Khatun, M Barras Supportive care in cancer 23, 71-78, 2015 | 163 | 2015 |
| Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches J Lindsay, M Dooley, J Martin, M Fay, A Kearney, M Barras Supportive Care in Cancer 22, 1113-1119, 2014 | 87 | 2014 |
| Azole antifungals and new targeted therapies for hematological malignancy J Lindsay, BW Teh, K Micklethwaite, M Slavin Current opinion in infectious diseases 32 (6), 538-545, 2019 | 53 | 2019 |
| Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021 BW Teh, DK Yeoh, GM Haeusler, CK Yannakou, S Fleming, J Lindsay, ... Internal Medicine Journal 51, 67-88, 2021 | 46 | 2021 |
| Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation J Lindsay, I Sandaradura, K Wong, C Arthur, W Stevenson, I Kerridge, ... Journal of Antimicrobial Chemotherapy 72 (12), 3414-3419, 2017 | 46 | 2017 |
| Effects of food and omeprazole on a novel formulation of super bioavailability itraconazole in healthy subjects J Lindsay, S Mudge, GR Thompson III Antimicrobial agents and chemotherapy 62 (12), 10.1128/aac. 01723-18, 2018 | 31 | 2018 |
| Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes J Lindsay, J Othman, MR Heldman, MA Slavin Current opinion in infectious diseases 34 (6), 635-645, 2021 | 21 | 2021 |
| Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic … W Jeong, P Haywood, N Shanmuganathan, J Lindsay, K Urbancic, ... Journal of Antimicrobial Chemotherapy 71 (12), 3540-3547, 2016 | 21 | 2016 |
| Epstein‐Barr virus related post‐transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation J Lindsay, MK Yong, M Greenwood, DCM Kong, SCA Chen, W Rawlinson, ... Reviews in Medical Virology 30 (4), e2108, 2020 | 18 | 2020 |
| Infection-related mortality in adults and children undergoing allogeneic hematopoietic cell transplantation: an Australian registry report J Lindsay, I Kerridge, L Wilcox, S Tran, TA O'Brien, M Greenwood, ... Transplantation and Cellular Therapy 27 (9), 798. e1-798. e10, 2021 | 16 | 2021 |
| New advances in the management of cytomegalovirus in allogeneic haemopoietic stem cell transplantation MK Yong, D Gottlieb, J Lindsay, J Kok, W Rawlinson, M Slavin, D Ritchie, ... Internal medicine journal 50 (3), 277-284, 2020 | 15 | 2020 |
| Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia J Lindsay, M Kabir, N Gilroy, G Dyer, L Brice, J Moore, M Greenwood, ... Cancer Medicine 5 (12), 3606-3614, 2016 | 13 | 2016 |
| Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patients J Coussement, J Lindsay, BW Teh, M Slavin Current Opinion in Infectious Diseases 34 (4), 297-306, 2021 | 12 | 2021 |
| Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre‐transplant predictors of survival, reactivation, and spontaneous clearance J Lindsay, J Othman, I Kerridge, K Fay, W Stevenson, C Arthur, SCA Chen, ... Transplant Infectious Disease 23 (3), e13548, 2021 | 10 | 2021 |
| Facing the challenges of new melanoma-targeted therapies: treatment of severe fevers associated with dabrafenib/trametinib combination therapy JN Lindsay, M Barras Journal of Oncology Pharmacy Practice 21 (4), 293-295, 2015 | 7 | 2015 |
| Voriconazole in hematopoietic stem cell transplantation and cellular therapies: Real-world usage and therapeutic level attainment at a major transplantation center J Lindsay, EM Krantz, J Morris, A Sweet, F Tverdek, A Joshi, R Yeh, ... Transplantation and Cellular Therapy 28 (8), 511. e1-511. e10, 2022 | 6 | 2022 |
| Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study M Bhurani, L Admojo, C Van Der Weyden, R Twigger, A Bazargan, ... Leukemia & lymphoma 62 (2), 330-336, 2021 | 6 | 2021 |
| Subtherapeutic concentrations of posaconazole tablet: determining risk factors and effectiveness of a standardized dose adjustment in hematology inpatients J Bui, R Gellatly, J Othman, J Lindsay Leukemia & Lymphoma 63 (14), 3418-3425, 2022 | 4 | 2022 |
| SUBA-itraconazole for primary antifungal prophylaxis after allogeneic hematopoietic cell transplantation J Lindsay, J Othman, Y Kong, A Yip, S Van Hal, S Larsen, C Bryant, ... Open Forum Infectious Diseases 8 (11), ofab502, 2021 | 4 | 2021 |
